Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC
This article is from
The Cancer Letter
archive.
Vol. 40 No. 47 | December 19, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
DCT Board Approves Drug Development Recompetition
November 30, 1990
TCL Archive
CDC Funds Early Detection Programs In Eight States
August 23, 1991
TCL Archive
Funding Opporunities: Program Announcments
January 15, 1999
TCL Archive
Symposium Planned On Grantmanship
April 20, 1984
TCL Archive
West Coast Symposium Reports Research Progress On Bone Cancer
November 1, 1974
TCL Archive
FDA Rile Changes Reporting Requirements for Adverse Events
November 18, 1994
